By Jennifer Chiou
New York, Sept. 27 - MitralSolutions, Inc said it raised $7 million in a series B preferred stock financing.
Cardinal Partners led investors.
"We see significant value in collaborating with the experts in cardiac valve repair and validating our core technologies in a surgical setting as the preferred process in developing reliable and effective percutaneous valve repair," said president and chief executive officer James L. Greene in a news release.
Proceeds will go towards the development of surgical and percutaneous medical devices for the treatment of valvular heart disease and congestive heart failure.
The company also said Lisa Skeete Tatum, general partner at Cardinal, will join its board.
Based in Ft. Lauderdale, Fla., MitralSolutions is an early-stage cardiovascular medical device company.
| Issuer: | MitralSolutions, Inc.
|
| Issue: | Preferred stock
|
| Amount: | $7 million
|
| Round: | Series B
|
| Investor: | Cardinal Partners (lead)
|
| Announcement date: | Sept. 27
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
